Properties

Laboratory Nexus is pleased to present this fully built-out molecular diagnostics laboratory located in Louisiana. This opportunity represents an exceptional chance for an existing laboratory operator, healthcare organization, diagnostics company, or investor seeking an operational laboratory platform without the time and expense of a ground-up build.

Laboratory Nexus is pleased to present a turnkey clinical laboratory opportunity located in Pennsylvania. This approximately 3,000 square foot laboratory has been built out to support both toxicology and molecular (PCR) testing and is available through an outright acquisition.

Turnkey opportunity to acquire a newly built, fully equipped molecular diagnostics laboratory located in the Houston metropolitan area. The laboratory has never billed or tested patient specimens, offering a clean operational history and allowing a buyer to launch operations without legacy billing, compliance, or payer issues.

Well-equipped high-complexity clinical laboratory located in the Dallas, Texas market available through an asset purchase.This sale is only for the turnkey buildout and does not include the CLIA.

Turnkey Laboratory Opportunity | Fully Equipped | Scalable Infrastructure A fully built-out New Jersey laboratory available for acquisition, offering a CLIA-certified and COLA-accredited platform with a successful inspection completed in December 2024. The laboratory is enrolled in Medicare and New Jersey Medicaid.

ASKING PRICE: $850,000 (ASSET PURCHASE) Laboratory Nexus is representing a Texas-based, CLIA-certified diagnostic laboratory specializing in clinical chemistry, immunology, hematology, and molecular testing, including PCR-based infectious disease panels.

We have a CLIA/COLA-accredited independent laboratory located in the Atlanta metro area that is turnkey and ready for a group prepared to begin their own testing. The facility has never submitted claims (100% cash-based) and recently passed a CMS inspection with zero deficiencies.

We’re representing a fully built-out, CLIA-certified high-complexity laboratory in Texas available for acquisition. This lab is validated for molecular PCR and blood testing, and comes equipped with a robust list of instrumentation and infrastructure.

A fully operational, CLIA-certified molecular laboratory located in Dallas, TX, is available for immediate acquisition. The lab is Medicare- and Texas Medicaid-approved, with robust infrastructure and top-tier equipment investments from previous ownership — presenting a true turnkey acquisition for any group looking to expand into the Novitas MAC region.

For Sale: High-Complexity Molecular PCR and Toxicology Laboratory in Arizona This is an excellent opportunity to acquire an established, profitable High Complexity, COLA-accredited laboratory specializing in Molecular PCR and Toxicology screening and confirmation. Operating as a turnkey facility, the laboratory occupies a well-built space with ample opportunity for growth.

Well-established CLIA-Certified In-Network full-service Laboratory in Alabama, fully equipped for Molecular and Blood Testing with QuantStudio 12k and 7k PCR setup, and Beckman instruments for blood testing. A unique chance to acquire a fully operational laboratory seamlessly integrated with BCBS Alabama, Medicare, Tricare, and multiple state Medicaids.

For Sale: Brand new High-Complexity CLIA laboratory in Maryland currently built out for Molecular PCR testing utilizing a ThermoFisher QuantStudio 5k instrument and KingFisher for extraction. The laboratory also includes a fully integrated LIS system and is credentialed with Medicare through the Novitas MAC. The owner is seeking $250k for an outright acquisition of all laboratory assets.